SS
VYGR icon

SBI Securities’s Voyager Therapeutics VYGR Stock Holding History

SBI Securities’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.14K Buy
1,755
+113
+7% +$429 ﹤0.01% 2089
2026
Q1 		$6.34K Buy
1,642
+240
+17% +$945 ﹤0.01% 1929
2025
Q4 		$5.51K Sell
1,402
-1
-0.1% -$4 ﹤0.01% 1980
2025
Q3 		$6.55K Buy
1,403
+1
+0.1% +$4 ﹤0.01% 1934
2025
Q2 		$4.36K Buy
1,402
+90
+7% +$290 ﹤0.01% 2048
2025
Q1 		$4.43K Buy
1,312
+18
+1% +$84 ﹤0.01% 1946
2024
Q4 		$7.34K Buy
+1,294
New +$8.34K ﹤0.01% 1775

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SBI Securities's VYGR Position: Q2 2026 in Review

SBI Securities increased its Voyager Therapeutics (VYGR) stake by 6.9% in Q2 2026, buying an estimated $429 and bringing the position to 1,755 shares worth $6.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2089.

SBI Securities first reported a position in VYGR in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.34K in Q4 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • SBI Securities held 1,755 shares of Voyager Therapeutics worth $6.14K as of Q2 2026.
  • SBI Securities bought 113 Voyager Therapeutics shares in Q2 2026, an estimated $429.
  • Voyager Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2089 holding.
  • SBI Securities first reported a position in Voyager Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Voyager Therapeutics position peaked at $7.34K in Q4 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.